This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs for psoriasis, a common skin disorder affecting an estimated 7.5 million people. While corticosteroid and other topical drugs are sufficient for many cases, potent immunosuppressant drugs are used in increasing numbers. This report also provides new evidence that drugs for erectile dysfunction and pulmonary arterial hypertension can cause deafness or sudden hearing loss.
To read this article, please click here.
More RSI News
Updated CSA Technical Guide for Infrastructure in Permafrost published
A second updated edition of the CSA national permafrost standard was published on May 21, 2019 and features climate and climate change information provided by…
RSI chairs panel session at Building the Next Generation of Canadian Infrastructure Conference
RSI chairs and presents on panel sessions for the Toronto conference, “Building the Next Generation of Canadian Infrastructure: Defining a roadmap for optimizing infrastructure planning,…
RSI Chairs Joint FAO/WHO Expert Meeting on Microbiological Risk Assessment (JEMRA)
RSI’s Dr. Emma Hartnett chaired the recent Joint FAO/WHO Expert Meeting on Microbiological Risk Assessment (JEMRA). The focus of the week-long event held March 11…
RSI partners with Engineers Canada to offer Online Workshop on the PIEVC Protocol
RSI and Engineers Canada are partnering to offer an online version of the introductory workshop on the PIEVC Protocol for infrastructure climate risk and vulnerability…